Cible Skin
- Region
- Asia,
Europe - Sectors
- Lifestyle
- Website
- https://www.cibleskin.com/
- Investment
- 2024 - Active
- Verlinvest contact
- Raphael Thiolon
About
Cible Skin takes a rigorous, research-backed approach to developing high-quality formulations, made in France with the best natural, clean, active ingredients, and offers skincare products including cleansers, serums, and moisturizers. The brand also offers a range of exclusive treatments at its flagship clinic in Paris, La Maison Cible Skin, providing customers with both a luxurious experience and personalized, technical and scientific guidance through their skincare journey.
Cible Skin draws on the expertise of its Scientific Committee, chaired by Co-Founder Dr. Raphaël Aknin, which combines decades of experience in regenerative medicine and immunological science to preserve the health, equilibrium, and beauty of the skin through the innovation of immuno-cosmetics. This clinically proven method boosts the immune system of skin cells to protect, regenerate and repair the skin, with powerful anti-aging, anti-imperfect, antioxidant, and ultra-moisturizing results.
In less than two years, the brand has gained a cult following amongst its customers, which include top celebrities, with La Maison Cible Skin named “the world’s best beauty clinic for anti-ageing treatments” by Forbes in 2023. Beyond its home market of France, Cible is growing rapidly, achieving multi-million dollars sales in China after launching there in March 2023.
Verlinvest invested in February 2024 to support the company’s unique immuno-cosmetic product development and continued global expansion.